Thomas M. Barnes - Net Worth and Insider Trading

Thomas M. Barnes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas M. Barnes owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .

Click here to see the complete history of Thomas M. Barnes’s form 4 insider trades.

Insider Ownership Summary of Thomas M. Barnes

Ticker	Comapny	Transaction Date	Type of Owner
NTLA	Intellia Therapeutics Inc	2016-05-05	Chief Scientific Officer

Thomas M. Barnes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas M. Barnes Ownership Network

Ownership Network List of Thomas M. Barnes

No Data

Ownership Network Relation of Thomas M. Barnes

Thomas M. Barnes Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Thomas M. Barnes is the Chief Scientific Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Thomas M. Barnes made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .

In summary, during the past 3 months, insiders sold 405 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 405 shares. During the past 18 months, 60,195 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,195 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Intellia Therapeutics Inc Insider Transactions

No Available Data

Thomas M. Barnes Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas M. Barnes. You might contact Thomas M. Barnes via mailing address: Intellia Therapeutics, Inc., 130 Brookline Street, Suite 201, Cambridge Ma 02139.

Discussions on Thomas M. Barnes

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.